---
figid: PMC7531624__fmolb-07-571092-g001
figtitle: Metabolites related to FMR1 premutation
organisms:
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Caenorhabditis elegans
- Homo sapiens
- Eucalyptus intertexta
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Arabidopsis thaliana
pmcid: PMC7531624
filename: fmolb-07-571092-g001.jpg
figlink: pmc/articles/PMC7531624/figure/F1/
number: F1
caption: Overview of metabolites related to FMR1 premutation. Altered metabolites
  identified in studies of plasma from FMR1 premutation carriers are shown in bold
  and in black. Altered metabolites identified in studies of FXTAS mice cerebellum
  are show in bold and in red. The up arrow indicates the increase, and the down arrow
  indicates the decrease. The “shunt” refers to the pentose phosphate shunt. The glycolysis
  pathway is outlined in red, with the pentose phosphate shunt outlined in a dashed
  red box. The TCA cycle is outlined in solid blue, and GABA metabolism is outlined
  in a dashed blue circle. Purine metabolism is outlined in purple, synthesis of polyunsaturated
  fatty acids is outlined in green, and sphingolipid metabolism is outlined in orange.
  AA, arachidonic acid; ALA, α-linolenic acid; AMP, Adenosine monophosphate; CoA,
  Coenzyme A; DHA, docosahexaenoic acid; DHGLA, dihomo-γ-linolenic acid; DPA, docosapentaenoic
  acid; EPA, eicosapentaenoic acid; FAD, Flavin adenine dinucleotide; GABA, γ-Aminobutyric
  acid; GHB, 4-hydroxybutyrate; GLA, Gamma linolenic acid; Gln, Glutamine; Glu, Glutamate;
  GMP, Guanosine monophosphate; IMP, Inosine monophosphate; LA, linoleic acid; LTB4,
  Leukotriene B4; MUFAs, monounsaturated fatty acids; NAD+, Nicotinamide adenine dinucleotide;
  PGA1, Prostaglandin A1; PGE2, Prostaglandin E2; PGF2a, Prostaglandin F2alpha; PGI2,
  prostaglandin I2; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids;
  SSA, succinic semialdehyde; TXA2, Thromboxane A2; XMP, Xanthosine monophosphate.
papertitle: Metabolic Alterations in FMR1 Premutation Carriers.
reftext: Yiqu Cao, et al. Front Mol Biosci. 2020;7:571092.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9301159
figid_alias: PMC7531624__F1
figtype: Figure
redirect_from: /figures/PMC7531624__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7531624__fmolb-07-571092-g001.html
  '@type': Dataset
  description: Overview of metabolites related to FMR1 premutation. Altered metabolites
    identified in studies of plasma from FMR1 premutation carriers are shown in bold
    and in black. Altered metabolites identified in studies of FXTAS mice cerebellum
    are show in bold and in red. The up arrow indicates the increase, and the down
    arrow indicates the decrease. The “shunt” refers to the pentose phosphate shunt.
    The glycolysis pathway is outlined in red, with the pentose phosphate shunt outlined
    in a dashed red box. The TCA cycle is outlined in solid blue, and GABA metabolism
    is outlined in a dashed blue circle. Purine metabolism is outlined in purple,
    synthesis of polyunsaturated fatty acids is outlined in green, and sphingolipid
    metabolism is outlined in orange. AA, arachidonic acid; ALA, α-linolenic acid;
    AMP, Adenosine monophosphate; CoA, Coenzyme A; DHA, docosahexaenoic acid; DHGLA,
    dihomo-γ-linolenic acid; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid;
    FAD, Flavin adenine dinucleotide; GABA, γ-Aminobutyric acid; GHB, 4-hydroxybutyrate;
    GLA, Gamma linolenic acid; Gln, Glutamine; Glu, Glutamate; GMP, Guanosine monophosphate;
    IMP, Inosine monophosphate; LA, linoleic acid; LTB4, Leukotriene B4; MUFAs, monounsaturated
    fatty acids; NAD+, Nicotinamide adenine dinucleotide; PGA1, Prostaglandin A1;
    PGE2, Prostaglandin E2; PGF2a, Prostaglandin F2alpha; PGI2, prostaglandin I2;
    PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids; SSA, succinic
    semialdehyde; TXA2, Thromboxane A2; XMP, Xanthosine monophosphate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - fliF
  - Imp
  - CG11110
  - CG17029
  - CG17028
  - CG17027
  - CG9391
  - CG9389
  - Mp
  - Coa
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Desat2
  - Fadd
  - Fad2
  - Desat1
  - Fancd2
  - dpa
  - La
  - wg
  - gl
  - aa
  - Nt5c2
  - Brap
  - Emp2
  - Hps3
  - Dpa
  - Ptgir
  - Gla
  - H2-Aa
  - NT5C2
  - IMPA1
  - BRAP
  - EMP2
  - BRCA2
  - FANCD2
  - PSEN1
  - GLA
  - NAT8
  - MP
  - NDP1
  - DPA
  - APG2
  - Glucose
  - Purine
  - Glucose 6-phosphate
  - GMP
  - AMP
  - Pyruvate
  - Guanosine
  - Xanthosinel Inosine t
  - Adenosine
  - Acetyl CoA
  - Fatty acids
  - Guanine
  - Xanthine
  - Hypoxanthine Adenine
  - Citrate
  - MUFAS
  - Oxaloacetate
  - Palmitic
  - Stearic
  - Palmitoleic
  - NAD
  - FAD
  - ALA
  - 18:4+20:4+EPA
  - DPA
  - DHA
  - Resolvins
  - Succinate
  - NADH
  - H
  - Eicosanoids
  - PGA2
  - PGE2
  - PGI2
  - TXA2, LTB4
  - Succinyl
  - Glu
  - DHGLA
  - Dihydrosphingosine 1-phosphate
  - Sphinganine
  - Dihydroceramide
  - Sphingosine 1-phosphate t
  - Sphingosine t
  - Ceramide
  - Sphingomyelin
---
